Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback

Lee, Stephen

104
Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback

Sunday, March 29, 2015: 3:05 PM

Salon C-D (Hilton Chicago)

S. J. Lee, R. S. Suidan, M. Quincy, Y. Sonoda, D. A. Levine, M. M. Leitao, G. J. Gardner, E. Jewell, O. Zivanovic and D. S. Chi
Memorial Sloan Kettering Cancer Center, New York, NY

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

104
Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback

104 Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback

104
Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback